Skip to Content

Pelagia Melea

Contributing Faculty

College of Health Professions

School of Health Sciences

Degree Program Ph.D. Public Health

Pelagia Melea holds a PhD (2016) in Pathology from the Medical School of National and Kapodistrian University of Athens, an MSc (2012) in Community Dentistry and a Bachelor degree in Dentistry (2002) from the Dental School of National and Kapodistrian University of Athens. She was a scientific collaborator in the Clinic and Laboratory of Preventive Dentistry department of Dental School, teaching undergraduate students for four years (2007-2011). She works as Visiting Lecturer and Researcher at Medical School of National and Kapodistrian University of Athens since 2010. She holds a private practice since 2003. Her recent interests include Public Health, Epidemiology, Community Health Promotion and Education, Quality of Life of Ontological Patients, Curriculum Development. She also has a track record of international and national publications and professional presentations. Dr. Melea has worked as a researcher in community-based research settings in a variety of areas including oral epidemiology, oncology, intellectually disabled individuals, individuals with substance abuse disorders and has served as a member of the methodology/statistics team in many of those projects.

Education

PhD, Medical School, National and Kapodistrian University of Athens - Ahtens, Greece

MS, Dental School, National and Kapodistrian University of Athens - Athens, Greece

BS, Dental School, National and Kapodistrian University of Athens - Athens, Greece

Public Service

Dental School, National and Kapodistrian University of Athens, Volunteer - Athens, Greece

Publications

Melea, P., Melakopoulos, I., Kastritis, E., Tesseromatis, C., Margaritis, V., Dimopoulos, M. A., Terpos, E. (2014). Conservative treatment of bisphosphonate-related osteonecrosis of the jaw in multiple myeloma patients.. International journal of dentistry.

Kastritis, E., Melea, P., Bagratuni, T., Melakopoulos, I., Gavriatopoulou, M., Roussou, M., Migkou, M., Eleutherakis-Papaiakovou, E., Terpos, E., Dimopoulos, M. A. (2017). Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy.. Leukemia & lymphoma.

Melea, P., Bagratouni, T., Terpos, E., Papaiakovou, E. E., Gavriatopoulou, M., Melakopoulos, I., Kastritis, E., Dimopoulos, M. A. (2014). Genetic Factors Related with Early Onset of Osteonecrosis of the Jaw in Patients with Multiple Myeloma Under Zoledronic Acid Therapy. Blood.

Kastritis, E., Terpos, E., Melakopoulos, I., Melea, P., Kalapanida, D., Roussou, M., Gavriatopoulou, M., Kanelias, N., Iakovaki, M., Christoulas, D., Gika, D., Dimopoulos, M. A. (2013). The Cumulative Dose But Not The Frequency Of Infusions Is a Risk Factor For The Development Of Osteonecrosis Of The Jaw (ONJ) In Myeloma Patients Who Receive Zoledronic Acid (ZA). Blood.

Melea, P., Koletsi-Kounari, H., Melakopoulos, I., Margaritis, V., Kastritis, E., Terpos, E., Dimopoulos, M. A. (2011). Oral health status of oncological patients receiving intravenous bisphosphonates. Stomatologia.

Presentations

Kastritis, E., Terpos, E., Melakopoulos, I., Melea, P., Kalapanida, D., Roussou, M., Gavriatopoulou, M., Kanelias, N., Iakovaki, M., Christoulas, D., Gika, D., Dimopoulos, M. A. (2013). The Cumulative Dose But Not The Frequency Of Infusions Is a Risk Factor For The Development Of Osteonecrosis Of The Jaw (ONJ) In Myeloma Patients Who Receive Zoledronic Acid (ZA). American Society of Hematology.

Melea, P., Melakopoulos, I., Tesseromati, C., Kastritis, E. (2016). Genetic Factors Related with Early Onset of Osteonecrosis of the Jaw in Patients with Multiple Myeloma Under Zoledronic Acid Therapy. Stomatological Society of Greece.

Melea, P., Melakopoulos, I., Kranias, N. (2011). Noninvasive clinical study of the oral health level of 185 oncology patients receiving intravenous bisphosphonates. Stomatological Society of Greece.

Melea, P., Melakopoulos, I., Kranias, N. (2012). Parenterally-administered drugs for the treatment of osteoporosis. What should the dentist watch out for. Stomatological Society of Greece.

Melea, P., Melakopoulos, I. (2013). Osteonecrosis of the jaw by intravenous anti-osteopenic drugs and surgical intervention prior to initiation of treatment. Stomatological Society of Greece.

Melea, P., Melakopoulos, I. (2018). Denosumab: Is there a risk of osteonecrosis of the jaw?. Stomatological Society of Greece.